Acetylation increases EWS-FLI1 DNA binding and transcriptional activity

Frontiers in Oncology

Volumn 2 SEP, Issue , 2012, Pages

  Schlottmann, Silke ^a   Erkizan, Hayriye V ^a   Barber Rotenberg, Julie S ^a   Knights, Chad ^a   Cheema, Amrita ^a   Üren, Aykut ^a   Avantaggiati, Maria L ^a   Toretsky, Jeffrey A ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Acetylation; Ewing's sarcoma; EWS FLI1; PCAF

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE INHIBITOR; HYBRID PROTEIN; RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR FLI 1;

ACETYLATION; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; CELL INCLUSION; CELL SURVIVAL; CONTROLLED STUDY; DENSITOMETRY; DNA BINDING; DNA TRANSCRIPTION; EWING SARCOMA; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUCIFERASE ASSAY; MASS SPECTROMETRY; MUTAGENESIS; NONHUMAN; PROTEIN PURIFICATION; TUMOR GROWTH; WESTERN BLOTTING;

EID: 84888581624     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00107     Document Type: Article

References (34)

1. Araya, N., Hirota, K., Shimamoto, Y., Miyagishi, M., Yoshida, E., Ishida, J., Kaneko, S., Kaneko, M., Nakajima, T., and Fukamizu, A. (2003). Cooperative interaction of EWS with CREB-binding protein selectively activates hepatocyte nuclear factor 4-mediated transcription. J. Biol. Chem. 278, 5427-5432.
2. Asano, Y., Czuwara, J., and Trojanowska, M. (2007). Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300/CREB-binding protein-associated factor-dependent acetylation. J. Biol. Chem. 282, 34672-34683.
3. Bai, Y., Srinivasan, L., Perkins, L., and Atchison, M. L. (2005). Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity. J. Immunol. 175, 5160-5169.
4. Beauchamp, E., Bulut, G., Abaan, O., Chen, K., Merchant, A., Matsui, W., Endo, Y., Rubin, J. S., Toretsky, J., and Uren, A. (2009). GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein. J. Biol. Chem. 284, 9074-9082.
5. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., and Mann, M. (2009). Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840.
6. Deneen, B., and Denny, C. T. (2001). Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation. Oncogene 20, 6731-6741.
7. Di Stefano, V., Soddu, S., Sacchi, A., and D'Orazi, G. (2005). HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage. Oncogene 24, 5431-5442.
8. Erkizan, H. V., Uversky, V. N., and Toretsky, J. A. (2010). Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma. Clin. Cancer Res. 16, 4077-4083.
9. Esiashvili, N., Goodman, M., and Marcus, R. B. Jr. (2008). Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: surveillance epidemiology and end results data. J. Pediatr. Hematol. Oncol. 30, 425-430.
10. Faiola, F., Liu, X., Lo, S., Pan, S., Zhang, K., Lymar, E., Farina, A., and Martinez, E. (2005). Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Mol. Cell. Biol. 25, 10220-10234.
11. Fouladi, M., Park, J. R., Stewart, C. F., Gilbertson, R. J., Schaiquevich, P., Sun, J., Reid, J. M., Ames, M. M., Speights, R., Ingle, A. M., Zwiebel, J., Blaney, S. M., and Adamson, P. C. (2010). Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report. J. Clin. Oncol. 28, 3623-3629.
12. Fuchs, B., Inwards, C. Y., and Janknecht, R. (2003). Upregulation of the matrix metalloproteinase-1 gene by the Ewing's sarcoma associated EWS-ER81 and EWS-Fli-1 oncoproteins, c-Jun and p300. FEBS Lett. 553, 104-108.
13. Fujimura, Y., Siddique, H., Lee, L., Rao, V. N., and Reddy, E. S. (2001). EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function. Oncogene 20, 6653-6659.
14. Furchert, S. E., Lanvers-Kaminsky, C., Juurgens, H., Jung, M., Loidl, A., and Fruhwald, M. C. (2007). Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood. Int. J. Cancer 120, 1787-1794.
15. Gangwal, K., Sankar, S., Hollenhorst, P. C., Kinsey, M., Haroldsen, S. C., Shah, A. A., Boucher, K. M., Watkins, W. S., Jorde, L. B., Graves, B. J., and Lessnick, S. L. (2008). Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc. Natl. Acad. Sci. U.S.A. 105, 10149-10154.
16. Goel, A., and Janknecht, R. (2003). Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu. Mol. Cell. Biol. 23, 6243-6254.
17. Hancock, J. D., and Lessnick, S. L. (2008). A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature. Cell Cycle 7, 250-256.
18. Jaboin, J., Wild, J., Hamidi, H., Khanna, C., Kim, C. J., Robey, R., Bates, S. E., and Thiele, C. J. (2002). MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors. Cancer Res. 62, 6108-6115.
19. Khoury, J. D. (2005). Ewing sarcoma family of tumors. Adv. Anat. Pathol. 12, 212-220.
20. Klevernic, I. V., Morton, S., Davis, R. J., and Cohen, P. (2009). Phosphorylation of Ewing's sarcoma protein (EWS) and EWS-Fli1 in response to DNA damage. Biochem. J. 418, 625-634.
21. Knights, C. D., Catania, J., Di Giovanni, S., Muratoglu, S., Perez, R., Swartzbeck, A., Quong, A. A., Zhang, X., Beerman, T., Pestell, R. G., and Avantaggiati, M. L. (2006). Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J. Cell Biol. 173, 533-544.
22. Nakatani, F., Tanaka, K., Sakimura, R., Matsumoto, Y., Matsunobu, T., Li, X., Hanada, M., Okada, T., and Iwamoto, Y. (2003). Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein. J. Biol. Chem. 278, 15105-15115.
23. Patel, J. H., Du, Y., Ard, P. G., Phillips, C., Carella, B., Chen, C. J., Rakowski, C., Chatterjee, C., Lieberman, P. M., Lane, W. S., Blobel, G. A., and McMahon, S. B. (2004). The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol. Cell. Biol. 24, 10826-10834.
24. Sakimura, R., Tanaka, K., Nakatani, F., Matsunobu, T., Li, X., Hanada, M., Okada, T., Nakamura, T., Matsumoto, Y., and Iwamoto, Y. (2005). Antitumor effects of histone deacetylase inhibitor on Ewing's family tumors. Int. J. Cancer 116, 784-792.
25. Smith, K. T., and Workman, J. L. (2009). Introducing the acetylome. Nat. Biotechnol. 27, 917-919.
26. Sonnemann, J., Dreyer, L., Hartwig, M., Palani, C. D., Hong Le, T. T., Klier, U., Broker, B., Volker, U., and Beck, J. F. (2007). Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing's sarcoma cells. J. Cancer Res. Clin. Oncol. 133, 847-858.
27. Spange, S., Wagner, T., Heinzel, T., and Kramer, O. H. (2009). Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int. J. Biochem. Cell Biol. 41, 185-198.
28. Tan, J., Cang, S., Ma, Y., Petrillo, R. L., and Liu, D. (2010). Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J. Hematol. Oncol. 3, 5.
29. Tanaka, K., Iwakuma, T., Harimaya, K., Sato, H., and Iwamoto, Y. (1997). EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J. Clin. Invest. 99, 239-247.
30. Thompson, P. R., Wang, D., Wang, L., Fulco, M., Pediconi, N., Zhang, D., An, W., Ge, Q., Roeder, R. G., Wong, J., Levrero, M., Sartorelli, V., Cotter, R. J., and Cole, P. A. (2004). Regulation of the p300 HAT domain via a novel activation loop. Nat. Struct. Mol. Biol. 11, 308-315.
31. Uren, A., Tcherkasskaya, O., and Toretsky, J. A. (2004). Recombinant EWS-FLI1 oncoprotein activates transcription. Biochemistry 43, 13579-13589.
32. Vervoorts, J., Luscher-Firzlaff, J. M., Rottmann, S., Lilischkis, R., Walsemann, G., Dohmann, K., Austen, M., and Luscher, B. (2003). Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 4, 484-490.
33. Zhang, K., Faiola, F., and Martinez, E. (2005). Six lysine residues on c-Myc are direct substrates for acetylation by p300. Biochem. Biophys. Res. Commun. 336, 274-280.
34. Zhang, K., Yau, P. M., Chandrasekhar, B., New, R., Kondrat, R., Imai, B. S., and Bradbury, M. E. (2004). Differentiation between peptides containing acetylated or tri-methylated lysines by mass spectrometry: an application for determining lysine 9 acetylation and methylation of histone H3. Proteomics 4, 1-10.